Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional

A Study of Galeterone Compared to Enzalutamide In Men Expressing Androgen Receptor Splice Variant-7 mRNA (AR-V7) Metastatic CRPC

ClinicalTrials.gov ID: NCT02438007

Public ClinicalTrials.gov record NCT02438007. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 7:44 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

ARMOR3-SV: A Phase 3, Randomized, Open Label, Multi-Center, Controlled Study of Galeterone Compared to Enzalutamide in Men Expressing Androgen Receptor Splice Variant-7 mRNA (AR-V7) Metastatic (M1) Castrate Resistant Prostate Cancer (CRPC)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to compare galeterone to enzalutamide in men expressing androgen receptor spice variant-7 mRNA (AR-V7) in metastatic (M1) castrate resistant prostate cancer (CRPC).

Study identification

NCT ID
NCT02438007
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
LTN PHARMACEUTICALS, INC.
Industry
Enrollment
953 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 2015 (Type not available)
Primary completion
Jul 2016 (Actual)
Completion
Nov 2016 (Actual)
Last update posted
Mar 15, 2023

2015 – 2016

United States locations

U.S. sites
51
U.S. states
23
U.S. cities
45
Facility City State ZIP Site status
Pinnacle Oncology Hematology Scottsdale Arizona 85258 —
University Of Arizona Cancer Center Tucson Arizona 85724 —
City of Hope Duarte California 91010 —
USC Norris Comprehensive Cancer Center Los Angeles California 90033 —
UCLA Jonsson Comprehensive Cancer Center Los Angeles California 90095 —
Prostate Oncology Specialists, Inc. Marina del Rey California 90292 —
UC Davis Cancer Center Sacramento California 95817 —
San Bernardino Urological Associates San Bernardino California 92404 —
Urology Speciality Group Torrance California 90505 —
University of Colorado Cancer Center Anschultz Cancer Pavilion Aurora Colorado 80045 —
The Urology Center of Colorado Denver Colorado 80211 —
Yale University School of Medicine New Haven Connecticut 06510 —
Georgetown University Medical Center Washington D.C. District of Columbia 20007 —
Sibley Memorial Hospital Washington D.C. District of Columbia 20016 —
Boca Raton Community Hospital, Inc. Boca Raton Florida 33486 —
University of Florida Health Cancer Center Orlando Florida 32806 —
Moffitt Cancer Center Tampa Florida 33612 —
First Urology Jeffersonville Indiana 47130 —
Tulane Medical Center New Orleans Louisiana 70115 —
Regional Urology, LLC Shreveport Louisiana 71106 —
University of Maryland Greenenbaum Cancer Center Baltimore Maryland 21201 —
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore Maryland 21205 —
Walter Reed National Military Medical Center Bethesda Maryland 20307 —
Massachusetts General Hospital Boston Massachusetts 02114 —
Dana-Farber Cancer Institute Boston Massachusetts 02115 —
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 —
University of Michigan Health System Ann Arbor Michigan 48109 —
Karmanos Cancer Center Detroit Michigan 48201 —
Urology Cancer Center and GU Research Network Omaha Nebraska 68130 —
Coastal Urology Associates Brick New Jersey 08724 —
Brooklyn Urology Research Group Brooklyn New York 11215 —
Advanced Urology Centers of New York Plainview New York 11803 —
Premier Medical Group of the Hudson Valley Poughkeepsie New York 12601 —
Associated Medical Professionals of NY Syracuse New York 13210 —
University of North Carolina Lineberger Cancer Center Chapel Hill North Carolina 27599 —
Carolina Urology Partners, PLLC Charlotte North Carolina 28277 —
Carolina Urology Partners Concord North Carolina 28025 —
The Urology Group Cincinnati Ohio 45212 —
Clinical Research Solutions Middleburg Heights Ohio 44130 —
Oregon Urology Institute Springfield Oregon 97477 —
Lancaster Urology Lancaster Pennsylvania 17604 —
Fox Chase Cancer Center Philadelphia Pennsylvania 19111 —
UPMC Cancer Centers Pittsburgh Pennsylvania 15232 —
Carolina Urologic Research Center Myrtle Beach South Carolina 29572 —
Urology Associates Clinical Research Nashville Tennessee 37209 —
Urology Clinics of North Texas Dallas Texas 75231 —
Texas Oncology/Baylor University Medical Center Dallas Texas 75246 —
Urology San Antonio San Antonio Texas 78229 —
Virginia Urology Richmond Virginia 23235 —
Urology of Virginia Virginia Beach Virginia 23462 —
The University of Wisconsin Paul P. Carbone Comprehensive Cancer Center Madison Wisconsin 53792 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 66 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02438007, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 15, 2023 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02438007 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →